Sinclair Cooper

Sinclair Cooper

Auto-generated profile, based on publicly available information

Sinclair Cooper

Centre for Immunity, Infection and Evolution, Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, United Kingdom

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CDCaroline E Dewar
Caroline E Dewar
PMPaula MacGregor
Paula MacGregor
SCSinclair Cooper
Sinclair Cooper
MGMatthew K Gould
Matthew K Gould
KMKeith R Matthews
Keith R Matthews
ASAchim C. Schnaufer
Achim C. Schnaufer
The sleeping sickness parasite Trypanosoma brucei has a complex life cycle, alternating between a mammalian host and the tsetse fly vector. A tightly controlled developmental programme ensures parasite transmission between hosts as well as survival within them and involves strict regulation of mitochondrial activities. In the glucose-rich bloodstream, the replicative ‘slender’ stage is thought to produce ATP exclusively via glycolysis and uses the mitochondrial F1FO-ATP synthase as an ATP hydrolysis-driven proton pump to generate the mitochondrial membrane potential (ΔΨm). The ‘procyclic’ stage in the glucose-poor tsetse midgut depends on mitochondrial catabolism of amino acids for energy production, which involves oxidative phosphorylation with ATP production via the F1FO-ATP synthase. Both modes of the F1FO enzyme critically depend on FO subunit a, which is encoded in the parasite’s mitochondrial DNA (kinetoplast or kDNA). Comparatively little is known about mitochondrial function and the role of kDNA in non-replicative ‘stumpy’ bloodstream forms, a developmental stage essential for disease transmission. Here we show that the L262P mutation in the nuclear-encoded F1 subunit γ that permits survival of ‘slender’ bloodstream forms lacking kDNA (‘akinetoplastic’ forms), via FO-independent generation of ΔΨm, also permits their differentiation into stumpy forms. However, these akinetoplastic stumpy cells lack a ΔΨm and have a reduced lifespan in vitro and in mice, which significantly alters the within-host dynamics of the parasite. We further show that generation of ΔΨm in stumpy parasites and their ability to use α-ketoglutarate to sustain viability depend on F1-ATPase activity. Surprisingly, however, loss of ΔΨm does not reduce stumpy life span. We conclude that the L262P γ subunit mutation does not enable FO-independent generation of ΔΨm in stumpy cells, most likely as a consequence of mitochondrial ATP production in these cells. In addition, kDNA-encoded genes other than FO subunit a are important for stumpy form viability. African trypanosomes are single cellular eukaryotes transmitted by tsetse flies that cause important diseases in humans and their livestock. For survival these parasites depend on their mitochondrion, an organelle that has its own genome (‘mtDNA’) and that is traditionally viewed as the ‘power plant’ of cells, but that has other essential roles as well. Interfering with mtDNA is an important part of how some anti-trypanosomatid drugs work. Most mitochondrial research in trypanosomes in the past has focused on forms of the sleeping sickness parasite that proliferate in the mammalian bloodstream or in the insect midgut, as these can be readily cultured in the laboratory. As a consequence, relatively little is known about mitochondrial biology of the so-called ‘stumpy’ form, a non-replicative stage that is critical for transmission to tsetse flies. In this study we use a mouse infection model to show that a certain gene mutation permits formation of stumpy forms that lack mtDNA. However, without mtDNA these parasites have an altered mitochondrial metabolism and a reduced life span, which tells us that stumpy forms depend on additional mtDNA-encoded genes that are not required by the proliferative bloodstream form.